Edition:
India

HTG Molecular Diagnostics Inc (HTGM.OQ)

HTGM.OQ on NASDAQ Stock Exchange Capital Market

3.64USD
12 Jan 2018
Change (% chg)

-- (--)
Prev Close
$3.64
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
127,336
52-wk High
$13.24
52-wk Low
$1.20

Latest Key Developments (Source: Significant Developments)

HTG Announces Preliminary Q4 And Full Year 2017 Unaudited Financial Results
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - HTG Molecular Diagnostics Inc ::HTG ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2017 UNAUDITED FINANCIAL RESULTS AND PROVIDES INITIAL 2018 REVENUE GUIDANCE.SEES Q4 2017 REVENUE $6.9 MILLION TO $7.2 MILLION.SEES FY 2017 REVENUE $13.8 MILLION TO $14.1 MILLION.SEES FY 2018 REVENUE $20 MILLION TO $25 MILLION.  Full Article

HTG Molecular, Illumina Agreed To Third Development Plan Under Parties' Amended & Restated Development & Supply Agreement
Thursday, 28 Dec 2017 

Dec 27 (Reuters) - HTG Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS - ON DEC 23, CO, ILLUMINA AGREED TO THIRD DEVELOPMENT PLAN UNDER PARTIES' AMENDED & RESTATED DEVELOPMENT & SUPPLY AGREEMENT.HTG MOLECULAR DIAGNOSTICS SAYS UNDER PLAN, ILLUMINA EXPECTED TO DEVELOP & DELIVER TO CO EXECUTABLE VERSION OF CUSTOM SOFTWARE - SEC FILING.  Full Article

HTG Molecular Diagnostics Expands Its Collaboration With Merck
Wednesday, 27 Dec 2017 

Dec 26 (Reuters) - Htg Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS EXPANDS ITS COLLABORATION WITH MERCK KGAA, DARMSTADT, GERMANY.HTG MOLECULAR - TO DEVELOP CUSTOM PROFILING ASSAY TO SUPPORT BIOMARKER RESEARCH FOR 6 INDICATIONS WITHIN MERCK KGAA'S DRUG DEVELOPMENT PIPELINE.  Full Article

HTG Molecular Diagnostics And Unit Of QIAGEN Amended First Statement Of Work Under Master Agreement
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Htg Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS - ON DEC. 18. CO, UNIT OF QIAGEN, AMENDED FIRST STATEMENT OF WORK UNDER MASTER AGREEMENT - SEC FILING.HTG MOLECULAR DIAGNOSTICS - UNDER AGREEMENT, QIAGEN AGREED TO PAY CO LOW, SINGLE‑DIGIT MILLIONS OF DOLLARS FOR NEXT‑PHASE ACTIVITIES FOR PROJECT.  Full Article

HTG Molecular Diagnostics reports third quarter earnings
Wednesday, 8 Nov 2017 

Nov 7 (Reuters) - Htg Molecular Diagnostics Inc :HTG Molecular Diagnostics reports 2017 third quarter earnings.Q3 loss per share $0.46.Sees FY 2017 revenue $10 million to $13 million.Q3 revenue $3.7 million.  Full Article

HTG Molecular Diagnostics Q2 loss per share $0.98
Wednesday, 10 Aug 2016 

Htg Molecular Diagnostics Inc : Q2 loss per share $0.98 . Htg molecular diagnostics reports second quarter 2016 results .Q2 revenue rose 140 percent to $1.9 million.  Full Article

HTG Molecular, Firalis to develop tool to predict response to anti-TNF-alpha therapies
Thursday, 7 Jul 2016 

HTG Molecular Diagnostics Inc : HTG Molecular Diagnostics and Firalis announce agreement to develop a theranostic tool to predict response to anti-TNF-alpha therapies for rheumatoid arthritis .Will supply instrumentation and reagents to support Firalis' development, validation, and clinical deployment of Rabiopred.  Full Article

HTG Molecular Diagnostics reports Q1 loss per share $1.02
Friday, 13 May 2016 

Htg Molecular Diagnostics Inc : Htg molecular diagnostics reports first quarter 2016 results . Q1 loss per share $1.02 .Q1 revenue $900,000.  Full Article

HTG Molecular diagnostics announces Immuno-oncology research collaboration agreement with Bristol-Myers Squibb
Friday, 13 May 2016 

Htg Molecular Diagnostics Inc : Htg will provide bristol-myers squibb access to its ngs-based htg edgeseq system . Companies will collaborate to develop tools for use for molecular profiling research for immuno-oncology .Htg molecular diagnostics announces immuno-oncology research collaboration agreement with bristol-myers squibb.  Full Article

HTG Molecular Diagnostics, Inc says distribution agreements with Gamidor in Israel and Durviz in Spain and Portugal
Tuesday, 12 Apr 2016 

HTG Molecular Diagnostics, Inc:Says distribution agreements with Gamidor Diagnostics in Israel and Durviz s.l. Parque Tecnológico de Valencia in Spain and Portugal to manage distribution of HTG's next generation sequencing (NGS)-based products.  Full Article

BRIEF-HTG Molecular, Illumina Agreed To Third Development Plan Under Parties' Amended & Restated Development & Supply Agreement

* HTG MOLECULAR DIAGNOSTICS - ON DEC 23, CO, ILLUMINA AGREED TO THIRD DEVELOPMENT PLAN UNDER PARTIES' AMENDED & RESTATED DEVELOPMENT & SUPPLY AGREEMENT